NCT06024109Recruiting
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Prospective, International, Randomized, Multicentric, Controlled Study on the Performance of SYMMCORA® Mid-term Unidirectional Barbed Suture Versus V-loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
The aim of this study is to show the superiority of the new unidirectional barbed suture (SYMMCORA® mid-term, unidirectional) to conventional suture material in terms of time to perform the vaginal cuff closure during gynecologic surgeries without an increase in the complication rate. Secondly, the superiority of SYMMCORA®, mid-term unidirectional compared to the V-Loc®, unidirectional will be assessed regarding the mean time to close the vaginal cuff. The study will be performed in routine clinical setting, the only difference will be the randomization into two different suture groups. Both suture materials which will be applied to approximate the vaginal cuff are approved and carrying the CE-marks. Additionally, both sutures will be applied in their intended use. Neither additional invasive measures nor additional burden in regard to the patient will be performed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 132 (estimated)
- First submitted
- 15 Aug 2023
- Start date
- 19 Mar 2024
- Primary completion date
- Jan 2027
- Lead sponsor
- Aesculap AG
- NCT number
- NCT06024109
What you commit to
- Study type: Observational
- Planned participants: 132
- From 19 Mar 2024 to the primary completion date, Jan 2027
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
- Open surgery
- Patients undergone immunosuppressive drug treatment within the prior 6 months
Other illness
- Patients with hypersensitivity or allergy to the suture material.
Other
- Participation in another clinical study
- Non-compliance of patient
Who the study is looking for
- Females undergoing an elective, laparoscopic total hysterectomy
- Age ≥ 18 years
- Written informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Klinikum Sachsenhausen der DGD Coordinator of this site? Confirm its status | Frankfurt am Main | Germany | Recruiting |
| Hospital Sant Joan de Déu de Manresa Coordinator of this site? Confirm its status | Manresa | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.